Clinical Study

Alga Ecklonia bicyclis, Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction: A Prospective, Randomized, Placebo-Controlled, Single-Blinded Study

Table 2

Mean changes from baseline to 3 months for primary and secondary outcomes.

Group AGroup B

IIEF-15, mean ± SD11.54 ± 2.47a,b1.32 ± 2.67
IIEF-EF, mean ± SD0.35 ± 1.420.04 ± 1.00
IIEF-IS, mean ± SD1.72 ± 1.63a,b0.05 ± 2.15
IIEF-OF, mean ± SD2.20 ± 1.51a,b0.08 ± 1.77
IIEF-SD, mean ± SD1.03 ± 1.35a,b0.41 ± 0.34
IIEF-OS, mean ± SD2.51 ± 1.45a,b0.57 ± 0.39
MSHQ-EjD, mean ± SD1.21 ± 2.03a,b0.24 ± 1.07
SQoL-M, mean ± SD10.20 ± 3.77a,b1.24 ± 2.53
PSV (cm/s), mean ± SD1.36 ± 0.75a,b0.21 ± 0.44
EDV (cm/s), mean ± SD0.24 ± 1.0 0.31 ± 0.9
Total testosterone (nmol/L),
mean ± SD
14.26 ± 2.0513.31 ± 1.32
Normal arterial function (PSV ≥35 cm/s) subgroup
 IIEF-EF, mean ± SD0.94 ± 3.680.10 ± 4.10
 PSV (cm/s), mean ± SD0.16 ± 0.750.10 ± 0.87
 MSHQ-EJD, mean ± SD1.41 ± 1.85a,b0.32 ± 1.54
 SQoL-M, mean ± SD8.76 ± 3.651.41 ± 3.21
Moderate arterial dysfunction (PSV ≥25 and <35 cm/s) subgroup
 IIEF-EF, mean ± SD1.82 ± 3.08a,b0.16 ± 2.69
 PSV (cm/s), mean ± SD1.56 ± 0.82a,b0.23 ± 0.63
 MSHQ-EJD, mean ± SD1.23 ± 1.84a,b0.11 ± 1.52
 SQoL-M, mean ± SD11.65 ± 3.12a,b1.18 ± 2.87
Severe arterial dysfunction (PSV <25 cm/s) subgroup
 IIEF-EF, mean ± SD0.54 ± 2.770.23 ± 2.41
 PSV (cm/s), mean ± SD0.05 ± 0.520.09 ± 0.74
 MSHQ-EJD, mean ± SD0.90 ± 2.560.25 ± 2.31
 SQoL-M, mean ± SD2.43 ± 2.891.21 ± 3.44

versus baseline; versus Group B.